Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of HHEX and SLC30A8 Gene Polymorphisms with Gestational Diabetes Mellitus Susceptibility: A Meta-analysis. | Biochem Genet | 2023 | 37103601 | PubTator, text mining | PubMed |
| Alternative CDC20 translational isoforms tune mitotic arrest duration. | Nature | 2023 | 37100900 | PubTator, text mining | PubMed |
| Self-emergent vortex flow of microtubule and kinesin in cell-sized droplets under water/water phase separation. | Commun Chem | 2023 | 37100870 | PubTator, text mining | PubMed |
| Gene dysregulation in acute HIV-1 infection - early transcriptomic analysis reveals the crucial biological functions affected. | Front Cell Infect Microbiol | 2023 | 37077524 | PubTator, text mining | PubMed |
| Neurodevelopmental and genetic findings in neonates with intracranial arteriovenous shunts: A case series. | Front Pediatr | 2023 | 37063679 | PubTator, text mining | PubMed |
| QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitors. | Comput Biol Chem | 2023 | 37062146 | PubTator, text mining | PubMed |
| Coordination between the Ndc80 complex and dynein is essential for microtubule plus-end capture by kinetochores during early mitosis. | J Biol Chem | 2023 | 37060995 | PubTator, text mining | PubMed |
| The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. | Cells | 2023 | 37048102 | PubTator, text mining | PubMed |
| Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs. | Int J Mol Sci | 2023 | 37047554 | PubTator, text mining | PubMed |
| A nine-gene signature as prognostic biomarker in gastric cancer by bioinformatics analysis. | Clin Transl Oncol | 2023 | 37041435 | PubTator, text mining | PubMed |
| A kinesin-based approach for inducing chromosome-specific mis-segregation in human cells. | EMBO J | 2023 | 37038978 | PubTator, text mining | PubMed |
| Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets. | Front Immunol | 2023 | 37033923 | PubTator, text mining | PubMed |
| Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets. | Clin Proteomics | 2023 | 37031178 | PubTator, text mining | PubMed |
| Advances in holliday junction recognition protein (HJURP): Structure, molecular functions, and roles in cancer. | Front Cell Dev Biol | 2023 | 37025176 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Cortical dynein drives centrosome clustering in cells with centrosome amplification. | Mol Biol Cell | 2023 | 37017483 | PubTator, text mining | PubMed |
| Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer. | Front Genet | 2023 | 37007961 | PubTator, text mining | PubMed |
| Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells. | J Cancer Res Clin Oncol | 2023 | 37000265 | PubTator, text mining | PubMed |
| Sanguinarine Exhibits Antiviral Activity against Porcine Reproductive and Respiratory Syndrome Virus via Multisite Inhibition Mechanisms. | Viruses | 2023 | 36992397 | PubTator, text mining | PubMed |
| Interleukin-10 as Covid-19 biomarker targeting KSK and its analogues: Integrated network pharmacology. | PLoS One | 2023 | 36989283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=25